We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

70 hedge funds and large institutions have $116M invested in Stemline Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

204% more call options, than puts

Call options by funds: $1.75M | Put options by funds: $575K

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

2% less capital invested

Capital invested by funds: $119M → $116M (-$2.84M)

7% less funds holding

Funds holding: 75 → 70 (-5)

33% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 15

Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
22
Reduced
22
Closed
15
Calls
$1.75M
Puts
$575K
Net Calls
+$1.18M
Net Calls Change
-$52K

Top Buyers

Rank Fund Capital Flow
1
Axa
Axa
France
+$1.63M
2
AG
Artal Group
Luxembourg
+$1.25M
3
LSC
Lyon Street Capital
California
+$1.05M
4
CCI
Columbus Circle Investors
+$1.05M
5
IBT
International Biotechnology Trust
United Kingdom
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$12.4M
2
VMI
VHCP Management II
New York
-$1.95M
3
GTC
Ghost Tree Capital
New York
-$1.92M
4
SM
Sabby Management
Florida
-$855K
5
Millennium Management
Millennium Management
New York
-$714K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$525K -$42.8K -5,137 -8%
TA
27
Teachers Advisors
New York
$399K +$4.51K +541 +1%
DMK
28
David M. Knott
$384K +$264K +31,692 +317%
Charles Schwab
29
Charles Schwab
California
$370K – – –
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$368K -$17.5K -2,100 -5%
Ameriprise
31
Ameriprise
Minnesota
$348K -$50.2K -6,020 -14%
TI
32
Trexquant Investment
Connecticut
$304K -$203K -24,294 -42%
Morgan Stanley
33
Morgan Stanley
New York
$298K +$4.08K +490 +2%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$286K – – –
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$252K +$35.7K +4,280 +19%
PAM
36
Panagora Asset Management
Massachusetts
$239K -$603K -72,273 -74%
CD
37
Carl Domino
Florida
$239K – – –
AQR Capital Management
38
AQR Capital Management
Connecticut
$235K – – –
UBS Group
39
UBS Group
Switzerland
$234K -$13.2K -1,586 -6%
TI
40
Telemetry Investments
New York
$230K +$12.3K +1,470 +6%
ARTA
41
A.R.T. Advisors
New York
$187K -$123K -14,700 -42%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$178K +$46K +5,522 +40%
AllianceBernstein
43
AllianceBernstein
Tennessee
$178K +$161K +19,300 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$167K -$148K -17,716 -49%
EMG
45
Ellington Management Group
Connecticut
$160K +$145K +17,400 New
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$147K +$133K +16,000 New
AIG
47
American International Group
New York
$129K +$28.9K +3,464 +33%
Wells Fargo
48
Wells Fargo
California
$126K – – –
Connor, Clark & Lunn Investment Management (CC&L)
49
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$118K +$107K +12,825 New
LTFS
50
Ladenburg Thalmann Financial Services
Florida
$117K – – –
1
2
3 4

STML Hedge Fund Activity: Q2 2017 in Review

70 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q2 2017, worth a combined $116M — down 2.4% from $119M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of STML and 10 opened new positions — a net loss of 5 holders — while 22 trimmed existing stakes and 22 added.

The largest buyer was Axa, adding an estimated $1.63M. The largest seller was Franklin Resources, exiting entirely with an estimated $12.4M sold.

  • 70 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q2 2017, down from 75 in Q1 2017.
  • Funds reported $116M of Stemline Therapeutics, Inc. stock for Q2 2017, down 2.4% quarter-over-quarter.
  • 10 funds opened new Stemline Therapeutics, Inc. positions in Q2 2017 and 15 closed out, a net change of -5 holders.
  • The largest Stemline Therapeutics, Inc. buyer in Q2 2017 was Axa, an estimated $1.63M added.
  • The largest Stemline Therapeutics, Inc. seller in Q2 2017 was Franklin Resources, an estimated $12.4M sold.

Based on aggregated 13F filings for Q2 2017.